Galadrim is developing the Vidal Ma Santé mobile application, which won the Galien prize for e-health innovation in 2022.
Galadrim is developing the Vidal Ma Santé mobile application, which won the Galien prize for e-health innovation in 2022.
VIDAL is at the heart of medical knowledge and has been developing ever more innovative information solutions for all healthcare professionals, patients, institutions and industry. This enables everyone to make the best health choices and take the right therapeutic decision at the right time.
Vidal markets its solutions in 30 countries around the world. In Europe, they are used by more than 700,000 professionals in the sector.
In 2021, the company has decided toexpand its offering by creating for the first time an application dedicated to patients. The goal: to offer the best mobile application to help patients take their medication and manage their treatment, especially those with chronic diseases.
VIDAL Ma Santé was created to meet this challenge. In 2022, it won the Galien prize for innovation in the e-health category.
In order to accompany him/her in taking his/her medication, the user can from the application :
complete your profile by filling in some key information
consult information on a drug by scanning its box or by performing a manual search
create a treatment by combining drugs
be alerted to drug interactions between your different treatments or between your treatments and your profile (pregnant women, breastfeeding, competitive sports, etc.). For example, some drugs may be contraindicated for pregnant women, young children, etc.
Receive reminders about medication and medical appointments through the calendar
One of the challenges of the project was the handling of health data. The choice was made to store all patient data securely on their phone.
Another challenge was to integrate services and APIs from Vidal's digital ecosystem. These APIs allow, for example, to collect information on drugs. We worked closely with their technical teams to manage these connections as well as possible.
To develop an optimal product adapted to the users' needs, two test phases were carried out.
A first group of patients was interviewed, prior to the design of the application, to identify the main difficulties associated with taking their medication. The most common difficulties encountered by the patients were:
poor understanding of the treatment
a difficulty in planning catches
the complexity and length of the notices
loss of effectiveness of treatments due to poor compliance
anxiety & risks related to iatrogeny
lack of visibility for caregivers
Taking into account these lessons, the models of the first version of the application were designed. This first version was then developed in agile methodology in 10 weeks.
A second phase of tests was carried out with 14 patients suffering from chronic diseases. These patients were monitored in their use of the application and had to answer a specific questionnaire. Their feedback allows the application to evolve continuously.